UA93032C2 - Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors - Google Patents

Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors

Info

Publication number
UA93032C2
UA93032C2 UAA200701488A UAA200701488A UA93032C2 UA 93032 C2 UA93032 C2 UA 93032C2 UA A200701488 A UAA200701488 A UA A200701488A UA A200701488 A UAA200701488 A UA A200701488A UA 93032 C2 UA93032 C2 UA 93032C2
Authority
UA
Ukraine
Prior art keywords
kinase inhibitors
map kinase
formula
disorder
triazolopyridinylsulfanyl
Prior art date
Application number
UAA200701488A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джон Пол Матіас
Девід Саймон Міллен
Расселл Ендрю Льютвейт
Крістофер Філліпс
Original Assignee
Пфайзер Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Інк. filed Critical Пфайзер Інк.
Priority claimed from PCT/IB2005/002574 external-priority patent/WO2006018718A2/en
Publication of UA93032C2 publication Critical patent/UA93032C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; Formula (I) and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease. EMBED ISISServer , (I)
UAA200701488A 2004-08-12 2005-08-09 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors UA93032C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0418015A GB0418015D0 (en) 2004-08-12 2004-08-12 New compounds
US69155905P 2005-06-17 2005-06-17
PCT/IB2005/002574 WO2006018718A2 (en) 2004-08-12 2005-08-09 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors

Publications (1)

Publication Number Publication Date
UA93032C2 true UA93032C2 (en) 2011-01-10

Family

ID=33017410

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200701488A UA93032C2 (en) 2004-08-12 2005-08-09 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors

Country Status (9)

Country Link
CN (1) CN101006087B (en)
GB (1) GB0418015D0 (en)
ME (1) ME01360B (en)
NI (1) NI200700039A (en)
PE (1) PE20060618A1 (en)
RS (1) RS50642B (en)
TW (1) TWI295926B (en)
UA (1) UA93032C2 (en)
ZA (1) ZA200700923B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0907463A2 (en) * 2008-02-04 2019-09-24 Pfizer Ltd polymorphic form of a [1,2,4] triazole [4,3-a] pyridine derivative for treating inflammatory diseases
PE20120655A1 (en) * 2009-02-17 2012-06-07 Chiesi Farma Spa TRIAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINES ACTIVATED BY MITOGEN P38 (MAP)
GB201009731D0 (en) * 2010-06-10 2010-07-21 Pulmagen Therapeutics Inflamma Kinase inhibitors
ES2612259T3 (en) * 2011-12-09 2017-05-16 Chiesi Farmaceutici S.P.A. Kinase inhibitors
CN105646484A (en) * 2016-03-01 2016-06-08 孙霖 Crystal form B and preparation method
CN105693716A (en) * 2016-03-01 2016-06-22 孙霖 Crystal form A and preparing method

Also Published As

Publication number Publication date
TW200610529A (en) 2006-04-01
ZA200700923B (en) 2008-09-25
GB0418015D0 (en) 2004-09-15
CN101006087B (en) 2010-09-29
NI200700039A (en) 2008-03-07
CN101006087A (en) 2007-07-25
RS50642B (en) 2010-06-30
ME01360B (en) 2010-06-30
PE20060618A1 (en) 2006-07-14
TWI295926B (en) 2008-04-21

Similar Documents

Publication Publication Date Title
MY140021A (en) Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
CY2021019I1 (en) N4-PHENYL-QUINAZOLINO-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPLOVARATIVE DISEASES
HK1093688A1 (en) 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
HRP20130895T1 (en) P38 map kinase inhibitors
TNSN08478A1 (en) Pyrazolo [3,4-d] pyrimidine derivatives useful to treat respiratory disorders
NO20070453L (en) Condensed heterocyclic kinase inhibitors
MY147442A (en) Imidazoquinolines as lipid kinase inhibitors
SG179437A1 (en) Pyrimidine hydrazide compounds as pgds inhibitors
WO2007126964A3 (en) Kinase inhibitors
WO2012173521A3 (en) Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
MY151172A (en) Pyrimidine amide compounds as pgds inhibitors
UA93032C2 (en) Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
MX2008009413A (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia.
TW200616967A (en) Novel indazole carboxamides and their use
ATE542800T1 (en) KINASE INHIBITORS AND THEIR METHODS OF APPLICATION
MX2010004967A (en) Use of cfms inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer.
WO2007124369A3 (en) Method of inhibiting c kit kinase
WO2006128674A3 (en) Combinations of indacaterol derivatives and other agents for the treatment of airway diseases
ES2174756A1 (en) Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
UY29057A1 (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS
DOP2005000152A (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS